Subcutaneous apomorphine in patients with advanced Parkinson's disease: a dose-escalation study with randomized, double-blind, placebo-controlled crossover evaluation of a single dose.
J Neurol Sci
; 258(1-2): 137-43, 2007 Jul 15.
Article
en En
| MEDLINE
| ID: mdl-17466338
Search on Google
Banco de datos:
MEDLINE
Asunto principal:
Enfermedad de Parkinson
/
Apomorfina
/
Antiparkinsonianos
Tipo de estudio:
Clinical_trials
/
Evaluation_studies
/
Observational_studies
/
Risk_factors_studies
Límite:
Aged
/
Female
/
Humans
/
Male
Idioma:
En
Año:
2007
Tipo del documento:
Article